Skip to content
10-Q

Quarterly Report

American CryoStem Corporation

0001019056-20-000354

← back to feed
Filed
May 20, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · May 18, 2020 50.84M sh
Current Liabilities Q2 2020 · Mar 31, 2020 $1.49M
Current Liabilities Q2 2020 · Sep 30, 2019 $1.29M
Total Liabilities Q2 2020 · Mar 31, 2020 $2.72M
Total Liabilities Q2 2020 · Sep 30, 2019 $2.53M
Current Assets Q2 2020 · Mar 31, 2020 $301.62K
Current Assets Q2 2020 · Sep 30, 2019 $379.81K
Total Assets Q2 2020 · Mar 31, 2020 $1.24M
Total Assets Q2 2020 · Sep 30, 2019 $1.29M
Capex Q2 2020 · Mar 31, 2019 $25.68K
Operating Cash Flow Q2 2020 · Mar 31, 2019 −$366.95K
Cash And Equivalents Q2 2020 · Mar 31, 2019 $19.55K
Cash And Equivalents Q2 2020 · Sep 30, 2018 $68.32K
Stockholders Equity restated Q2 2020 · Mar 31, 2019 −$966.82K
Stockholders Equity Q2 2020 · Dec 31, 2018 −$907.34K
Stockholders Equity Q2 2020 · Sep 30, 2018 −$700.45K
Net Income Q2 2020 · Mar 31, 2019 −$352.1K
Net Income Q2 2020 · Mar 31, 2019 −$646.53K
Operating Income Q2 2020 · Mar 31, 2019 −$323.35K
Operating Income Q2 2020 · Mar 31, 2019 −$584.71K
Gross Profit Q2 2020 · Mar 31, 2019 $23.61K
Gross Profit Q2 2020 · Mar 31, 2019 $134.04K
Cost Of Revenue Q2 2020 · Mar 31, 2019 $20.71K
Cost Of Revenue Q2 2020 · Mar 31, 2019 $25.67K
Revenue Q2 2020 · Mar 31, 2019 $44.32K
Revenue Q2 2020 · Mar 31, 2019 $159.71K